Business Wire

Business Wire
Share

Business Wire

 •  October 6

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global cath lab services market to grow at a CAGR of almost 6% during the forecast period, according to their latest report. Global cath lab services market is set to grow at a CAGR of almost 6% during the period, 2017-2021. @Technavio Tweet this The research study covers the present scenario...

Business Wire

 •  October 3

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, will showcase its broad portfolio of products for Respiratory Care at the 70th Anniversary of the American Association for Respiratory Care (AARC) Congress, October 4-7, 2017 in Indianapolis. “The...

Business Wire

 •  September 26

IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improving treatment of Acute Myocardial Infarction (AMI), announced that the U.S. Food and Drug Administration (FDA) has accepted the Premarket Approval (PMA) application for its Supersaturated Oxygen (SSO2) Therapy system. The second-generation SSO2...

Business Wire

 •  September 13

SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections using bacteriophage technology, announces the first-in-human intravenous administration of AmpliPhi’s drug candidate AB-SA01. AmpliPhi supplied AB-SA01...

Business Wire

 •  September 12

SAN DIEGO--(BUSINESS WIRE)--Access Scientific, LLC has been awarded a group purchasing agreement for midline vascular access catheters with Premier Inc. effective December 1, 2017. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Access Scientific’s line of...

Business Wire

 •  September 6

SAN DIEGO--(BUSINESS WIRE)--Access Scientific, LLC today announced the much-anticipated release of its new POWERWAND™ ED, a rapid venous access device that delivers the first- and best-in-class POWERWAND (6cm/2.4 inch) Extended Dwell Catheter in seconds, using the proprietary accelerated Seldinger technique (AST). The POWERWAND ED allows clinicians...

Business Wire

 •  August 21

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the...

Business Wire

 •  August 17

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that it will be featuring IV Clear while exhibiting for the first time at the 41st Association of Pediatric Hematology/Oncology Nurses annual conference and exhibit at the Palm Springs...

Business Wire

 •  August 15

SAN DIEGO--(BUSINESS WIRE)--When central venous access for high-flow fluid resuscitation and drug administration is urgent, Access Scientific now has the answer — the POWERWAND™ CVC. Recently cleared by FDA for central venous access, this 16 gauge, single-lumen POWERWAND can be inserted, using the proprietary Accelerated Seldinger Technique (AST),...

Business Wire

 •  July 6

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today the U.S. Food and Drug Administration (FDA) has approved ORENCIA for the treatment of adults with active Psoriatic Arthritis (PsA)1, a chronic2, inflammatory disease that can affect both the skin and musculoskeletal system.3 ORENCIA is approved and available...